Found 10 matching trials
PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients PHASE1 This is a Phase 1, randomized, open-label, 2-way crossover, pharmacokinetic...
Show More Location
Multiple Locations
Learn More & Join Trial
The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission. NA A clinical study was conducted to evaluate the efficacy and safety of the R...
Show More Location
The First Bethune Hospital of Jilin University
Learn More & Join Trial
CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma PHASE2 This is a prospective, single arm, multicenter study to evaluate the safety...
Show More Location
Multiple Locations
Learn More & Join Trial
Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia PHASE2 Any time the words "you," "your," "I," or "me" appear, it is meant to apply...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma PHASE1 This study evaluates addition of Vincristine Sulfate Liposome Injection (Ma...
Show More Location
Rhode Island Hospital and The Miriam Hospital
Learn More & Join Trial
R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse PHASE2 This is a double-center, single-arm, phase 2 study to evaluate the efficacy...
Show More Learn More & Join Trial
Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHL PHASE1 This was a Phase 1/2 study performed at two clinical centers in the US and ...
Show More Location
University of California
Learn More & Join Trial
Treatment for Advanced B-Cell Lymphoma PHASE2 To safely reduce the burden of therapy in children, adolescents and young a...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
R-CMOP in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma PHASE1 This is a prospective clinical study to evaluate the safety and efficacy of...
Show More Location
Institute of Hematology & Blood Disease Hospital
Learn More & Join Trial
Sintilimab Plus R-CHOP as the First-line Treatment in Patients With Diffuse Large B-Cell Lymphoma. PHASE2 The purpose of this study is to evaluate the efficacy and safety of Sintili...
Show More Location
Multiple Locations
Learn More & Join Trial